BOD Science Ltd Market Cap ($3.01 Million)
Market Cap & Net Worth: BOD Science Ltd (BOD)
BOD Science Ltd market cap. BOD Science Ltd (AU:BOD) has a market capitalization of $3.01 Million (AU$4.26 Million) as of November 7, 2026. Listed on the AU stock exchange, this Australia-based company holds position #29420 globally and #1639 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BOD Science Ltd's stock price AU$0.02 by its total outstanding shares 177338000 (177.34 Million). Also see BOD cash flow conversion for how efficiently the company converts equity into cash flow.
BOD Science Ltd Market Cap History (2016–2025)
BOD Science Ltd market cap history from 2016 to 2025. Data shows change from $23.21 Million to $3.01 Million (-23.94% CAGR). Check today's stock price for BOD Science Ltd for real-time trading data and today's change.
BOD Science Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BOD Science Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore BOD net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.90x
BOD Science Ltd's market cap is 0.90 times its annual revenue
Latest Price to Earnings (P/E) Ratio
11.63x
BOD Science Ltd's market cap is 11.63 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $23.21 Million | $138.02K | -$283.80K | 168.19x | N/A |
| 2017 | $48.94 Million | $352.88K | -$3.17 Million | 138.68x | N/A |
| 2018 | $48.94 Million | $852.78K | -$3.67 Million | 57.38x | N/A |
| 2019 | $37.64 Million | $820.22K | -$7.62 Million | 45.89x | N/A |
| 2020 | $61.48 Million | $5.01 Million | -$4.82 Million | 12.26x | N/A |
| 2021 | $30.11 Million | $6.58 Million | -$4.23 Million | 4.58x | N/A |
| 2022 | $18.82 Million | $3.42 Million | -$5.41 Million | 5.50x | N/A |
| 2023 | $3.01 Million | $1.72 Million | -$7.95 Million | 1.75x | N/A |
| 2024 | $3.01 Million | $875.56K | -$6.41 Million | 3.44x | N/A |
| 2025 | $3.01 Million | $3.34 Million | $258.98K | 0.90x | 11.63x |
Competitor Companies of BOD by Market Capitalization
Companies near BOD Science Ltd in the global market cap rankings as of November 7, 2026. Also see balance sheet size of BOD Science Ltd for a full breakdown of the balance sheet.
Key companies related to BOD Science Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #506 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #532 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #570 globally with a market cap of $46.85 Billion USD ( CN¥320.16 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #615 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #506 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #532 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.40 |
| #570 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.85 Billion | CN¥50.19 |
| #615 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €19.30 |
Market Capitalization of BOD Science Ltd (2016–2025)
Market capitalization of BOD Science Ltd from 2016 to today. Between 2016 and today, BOD Science Ltd's market cap moved from $23.21 Million to $ 3.01 Million, with a yearly change of -23.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | AU$3.01 Million | 0.00% |
| 2024 | AU$3.01 Million | 0.00% |
| 2023 | AU$3.01 Million | -84.00% |
| 2022 | AU$18.82 Million | -37.50% |
| 2021 | AU$30.11 Million | -51.02% |
| 2020 | AU$61.48 Million | +63.33% |
| 2019 | AU$37.64 Million | -23.08% |
| 2018 | AU$48.94 Million | 0.00% |
| 2017 | AU$48.94 Million | +110.81% |
| 2016 | AU$23.21 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of BOD Science Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.01 Million USD |
| MoneyControl | $3.01 Million USD |
| MarketWatch | $3.01 Million USD |
| marketcap.company | $3.01 Million USD |
| Reuters | $3.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BOD Science Ltd
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and dis… Read more